NeuroScientific Biopharmaceuticals Limited Price (NSB.AX)

Stock Price

Low: Year Low
High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Fetching Data...

Shares Outstanding

144,508,886

(0.723)%

NeuroScientific Performance History

Community Sentiment 0 votes
↑ 0% ↓ 0%

Description

NeuroScientific Biopharmaceuticals Limited develops therapeutic treatments for neurodegenerative diseases through preclinical and clinical studies of patented technologies. Its lead drug candidates include EmtinB for treatment of neurodegenerative dementia and Alzheimer's disease, and degenerative conditions of the optic nerve. The company was incorporated in 2002 and is based in Cottesloe, Australia. Read More

Sector: Healthcare

  • Previous Close Fetching Data...
  • Range $0.033-0.078
  • Market Cap 5.93M
  • Enterprise Value No Data
  • Avg Volume Fetching Data...
  • P/E Ratio Fetching Data...
  • Dividend Yield Fetching Data...

Industry: Biotechnology

  • ceo: Dr. Anthony James Keating
  • IPO Date: July, 27, 2018
  • Country: AU
  • Currency: AUD
  • Headquaters: Cottesloe, WA
  • Employees: No Data

- Revenue from each product or segment:

Product or Segment Value: % - Total Last 3Y:
news-img

- Revenue by Region

Product or Segment Value: % - Total Last 3Y:
news-img
8 New Orders
close
Theme Customizer

Customize your theme

close

Theme variation